The 'Switch’ study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis…

Overview of attention for article published in BMC Musculoskeletal Disorders, December 2014

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 1,757 followers.

Switch study: a randomised-controlled trial of switching to alternative TNF-inhibitor drug, abatacept or rituximab. http://t.co/LzR7QdHuQ1

Switch study: a randomised-controlled trial of switching to alternative TNF-inhibitor drug, abatacept or rituximab. http://t.co/LzR7QdHuQ1

Background: Rheumatoid Arthritis (RA) is one of the most common autoimmune diseases, affecting approximately 1%... http://t.co/KGoaEwZhZ8

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.